Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Inflammatory Bowel Diseases

  Free Subscription


5 Aliment Pharmacol Ther
1 BMC Gastroenterol
1 Dig Dis Sci
1 Dis Colon Rectum
1 Gut
7 Inflamm Bowel Dis
1 J Clin Gastroenterol
4 J Crohns Colitis
1 J Gastroenterol
2 Lancet Gastroenterol Hepatol
6 Minerva Gastroenterol (Torino)
2 PLoS One
1 Z Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. NEDUMANNIL L, Mohamedrashed M, Bohra A, Sood S, et al
    Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease.
    Aliment Pharmacol Ther. 2024;59:1162-1163.

  2. BARTH I, Stevens CL, Strokap CJ, Campmans-Kuijpers MJE, et al
    Letter: Diet-microbiome interactions in inflammatory bowel disease-Navigating towards individualised dietary strategies.
    Aliment Pharmacol Ther. 2024;59:1154-1155.

  3. THWAITES PA, Gibson PR
    Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease. Authors' reply.
    Aliment Pharmacol Ther. 2024;59:1164-1165.

    Editorial: Time to address quality of life in our IBD treatment-IBD nurse intervention as a key part of multimodal IBD management.
    Aliment Pharmacol Ther. 2024;59:1152-1153.

  5. ALIU A, Bosch DHCA, Keszthelyi D, Rezazadeh Ardabili A, et al
    Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission.
    Aliment Pharmacol Ther. 2024 Apr 8. doi: 10.1111/apt.17988.
    PubMed         Abstract available

    BMC Gastroenterol

  6. HU N, Liu J, Gao X, Tang H, et al
    Correction: The association between hemoglobin level and sarcopenia in Chinese patients with Crohn's disease.
    BMC Gastroenterol. 2024;24:130.

    Dig Dis Sci

  7. VAN LINSCHOTEN RCA, Jansen FM, Pauwels RWM, Smits LJT, et al
    A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
    Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08410.
    PubMed         Abstract available

    Dis Colon Rectum

  8. KNOWLES JP, Church J
    Normal Ileal Mucus Is Inadequate for Epithelial Protection in Ileal Pouch Mucosa.
    Dis Colon Rectum. 2024;67:635-644.
    PubMed         Abstract available


  9. RIEDER F, Mukherjee PK, Massey WJ, Wang Y, et al
    Fibrosis in IBD: from pathogenesis to therapeutic targets.
    Gut. 2024;73:854-866.
    PubMed         Abstract available

    Inflamm Bowel Dis

  10. DRYGIANNAKIS I, Kolios G, Filidou E, Bamias G, et al
    Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Apr 6:izae066. doi: 10.1093.
    PubMed         Abstract available

  11. KAYALI S, Fantasia S, Gaiani F, Cavallaro LG, et al
    NOD2 and Crohn's Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired.
    Inflamm Bowel Dis. 2024 Apr 6:izae075. doi: 10.1093.
    PubMed         Abstract available

  12. IWAMA I, Yoshida M, Miyazawa A, Hara T, et al
    Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Apr 8:izae078. doi: 10.1093.

  13. ROWAN C, Yeaman F, Ernest-Suarez K, Martin ML, et al
    Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.
    Inflamm Bowel Dis. 2024 Apr 9:izae076. doi: 10.1093.

  14. CARTIER L, Loiez A, Nachury M, Azahaf M, et al
    Changes Over Time in the Lemann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2024 Apr 10:izae073. doi: 10.1093.
    PubMed         Abstract available

  15. INNOCENTI T, Dragoni G
    Bowel Damage and Disability in Crohn's Disease: Is it Really Two Birds with One Stone?
    Inflamm Bowel Dis. 2024 Apr 10:izae050. doi: 10.1093.

  16. HAWKINS RL, Zia M, Hind D, Lobo AJ, et al
    Inequalities in Healthcare Access, Experience and Outcomes in Adults With Inflammatory Bowel Disease: A Scoping Review.
    Inflamm Bowel Dis. 2024 Apr 11:izae077. doi: 10.1093.
    PubMed         Abstract available

    J Clin Gastroenterol

  17. PETROV JC, Al-Bawardy B, Alzahrani R, Mohamed G, et al
    Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2024 Apr 10. doi: 10.1097/MCG.0000000000002003.
    PubMed         Abstract available

    J Crohns Colitis

  18. ZADORA W, Innocenti T, Verstockt B, Meijers B, et al
    Chronic kidney disease in inflammatory bowel disease, a systematic review and meta-analysis.
    J Crohns Colitis. 2024 Apr 8:jjae049. doi: 10.1093.
    PubMed         Abstract available

  19. TIONG HT, Fan D, Frampton C, Ananthakrishnan AN, et al
    Physical Activity Is Associated With A Decreased Risk Of Developing Inflammatory Bowel Disease: A Systematic Review And Meta-Analysis.
    J Crohns Colitis. 2024 Apr 10:jjae053. doi: 10.1093.
    PubMed         Abstract available

  20. MOHAMEDRASHED M, Garg M, Bohra A
    Advocating for Consensus: The crucial role of standardised Magnetic resonance imaging (MRE) protocols and image quality metrics in assessment of Crohn's disease.
    J Crohns Colitis. 2024 Apr 12:jjae051. doi: 10.1093.

  21. PETIT P, Leroyer A, Chamot S, Fumery M, et al
    Farming activities and risk of inflammatory bowel disease: a French nationwide population-based cohort study.
    J Crohns Colitis. 2024 Apr 12:jjae050. doi: 10.1093.
    PubMed         Abstract available

    J Gastroenterol

  22. MAKUUCHI M, Kakuta Y, Umeno J, Fujii T, et al
    Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.
    J Gastroenterol. 2024 Apr 8. doi: 10.1007/s00535-024-02099.
    PubMed         Abstract available

    Lancet Gastroenterol Hepatol

  23. FUMERY M, Buisson A
    Has the time come for a systematic top-down approach in Crohn's disease?
    Lancet Gastroenterol Hepatol. 2024;9:394-395.

  24. BETHLEHEM L, Estevinho MM, Grinspan A, Magro F, et al
    Microbiota therapeutics for inflammatory bowel disease: the way forward.
    Lancet Gastroenterol Hepatol. 2024;9:476-486.
    PubMed         Abstract available

    Minerva Gastroenterol (Torino)

  25. FANTINI MC, Onali S, Gasbarrini A, Lopetuso LR, et al
    Immune system and gut microbiota senescence in elderly IBD patients.
    Minerva Gastroenterol (Torino). 2024;70:59-67.
    PubMed         Abstract available

  26. LEONCINI G, Reggiani-Bonetti L, Simoncelli G, Villanacci V, et al
    Histology of IBD and related colitides in the elderly.
    Minerva Gastroenterol (Torino). 2024;70:68-78.
    PubMed         Abstract available

  27. CASTIGLIONE F, Imperatore N, Zingone F, D'Inca R, et al
    Therapy in elderly IBD patients.
    Minerva Gastroenterol (Torino). 2024;70:89-97.
    PubMed         Abstract available

  28. INGRASCIOTTA Y, Grova M, Crispino F, Isgro V, et al
    Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients.
    Minerva Gastroenterol (Torino). 2024;70:98-108.
    PubMed         Abstract available

  29. VIOLA A, Fiorino G, Costantino G, Fries W, et al
    Epidemiology and clinical course of late onset inflammatory bowel disease.
    Minerva Gastroenterol (Torino). 2024;70:52-58.
    PubMed         Abstract available

  30. BELLONE F, Sardella A, Muscianisi M, Basile G, et al
    Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease.
    Minerva Gastroenterol (Torino). 2024;70:79-88.
    PubMed         Abstract available

    PLoS One

  31. HU J, Huang Y, Jia R, Wang X, et al
    Absolute monocyte counts could predict disease activity and secondary loss of response of patients with Crohn's disease treated with anti-TNF-alpha drug.
    PLoS One. 2024;19:e0301797.
    PubMed         Abstract available

  32. FU W, Zhu B, Chen J, Jin X, et al
    Risk relationship between inflammatory bowel disease and urolithiasis: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0301545.
    PubMed         Abstract available

    Z Gastroenterol

  33. SCHMIDT C, Stallmach A, Sturm A, Bachmann O, et al
    [Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease with regard to COVID-19 (version 2.0)].
    Z Gastroenterol. 2024;62:517-534.

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.